Current role
Carolyn Shelton
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carolyn Shelton
Nexalin Technology, Inc. reported in an 8-K filed September 19, 2024 that Carolyn Shelton was appointed Senior Vice President Quality, Regulatory and Clinical Affairs, effective September 16, 2024. The proxy statement of Nexalin Technology, Inc. reports total compensation of $391,180 for Carolyn Shelton in fiscal 2025, including a base salary of $300,000. Disclosed compensation is on record for 2 fiscal years.
“On September 16, 2024, Nexalin Technology, Inc. (“Nexalin”) appointed Carolyn Shelton as Senior Vice President Quality, Regulatory and Clinical Affairs, effective as of September 16, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Nexalin Technology, Inc. (NXL)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Nexalin Technology, Inc.
Other people whose current roles at this company are on record from its filings.
- Mark White CEO, Board Member
- Justin Van Fleet CFO
- Alan Kazden Board Member
- Ben V. Hu Board Member
- David Owens Board Member
- Leslie Bernhard Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Nexalin Technology, Inc. (NXL) | Senior Vice-President of Quality, Clinical and Regulatory | $300,000 | $391,180 |
| 2024 | Nexalin Technology, Inc. (NXL) | Senior Vice-President of Quality, Clinical and Regulatory | $93,500 | $288,034 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.